Healthcare DIVE April 3, 2025
Rebecca Pifer

The FTC says it doesn’t have enough active commissioners to move forward after President Donald Trump fired two Democrats last month.

Dive Brief:

  • The Federal Trade Commission is pausing its litigation against major pharmacy benefit managers, saying it doesn’t have enough commissioners to try the case after President Donald Trump fired two Democrats last month.
  • The lawsuit filed last year by the Biden administration accuses Caremark, Express Scripts and Optum Rx — the so-called “Big Three” PBMs that are owned by CVS, Cigna and UnitedHealth, respectively — of artificially inflating the cost of insulin, driving up prices for payers and patients.
  • However, the FTC’s general counsel issued a stay in the case on Tuesday, saying “there are currently no...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Govt Agencies, Pharma, Pharma / Biotech
Related Articles:
Pharma Dodges The Tariff Bullet — But For How Long?
Robots can aid hospital pharmacies in safer and more sustainable cancer drug preparation
PBM Private Labeling Boosts Biosimilars, Raises Concerns
Q&A: How can drug repurposing lower drug costs and improve care?
GoodRx Launches eCommerce Offering for Retail Pharmacies

Share This Article